3634 results for «2002»
3634 results
Acute coronary syndromes caused by left main coronary lesions requiring emergency intervention
15 May 2024 – From EuroPCR 2024

Antegrade CTO PCI: how to develop a consistent and systematic strategy ?
14 May 2024 – From EuroPCR 2024
This replay provides a comprehensive guide to mastering antegrade wire escalation (AWE), managing failed procedures, and utilizing IVUS to address ambiguous proximal caps. Additionally, learn when to stop in the event of a failed case and explore alternative strategies to ensure optimal patient outcomes.

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...

The challenge with ostial CTO lesions
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the challenges in treating ostial chronic total occlusion (CTO) lesions. It covers various case presentations and discussions, including the use of specialized techniques and devices to tackle calcified and stumpless ostial right coronary artery CTOs,...

Alain G. Cribier
07 Nov 2017
In 2002, Alain Cribier revolutionised the field by introducing transcatheter aortic valve implantation (TAVI) as a complementary technique to surgery. Find out more about his early life and studies.

Transcatheter aortic valve implantation (TAVI)
10 Sep 2025
Aortic stenosis (AS) is the most common valvular heart disease leading to intervention. It is characterized by progression from leaflet thickening and calcification to significant haemodynamic stenosis which results in disease-specific symptoms and physical limitations as well as poor prognosis and impaired quality of life if...
Authors :

Aortic stenosis prevalence and balloon aortic valvuloplasty
08 Nov 2017
The transformation in the field of interventional cardiology is unprecedented. Today, interventional cardiology encompasses an ever-growing list of diagnostic and therapeutic percutaneous procedures performed in the cathlab.

PCRonline announces its new Editor-in-Chief!
14 Feb 2020
Salvatore Brugaletta is an Interventional Cardiologist at the “Hospital Clínic de Barcelona”, Spain and associate professor of Medicine at the University of Barcelona. Highly skilled in Clinical Research, Medical Education and Medical Devices with strong commitment inside medical communities, he received two PhD degrees focused on interventional cardiology from Erasmus University (Rotterdam,...

In remembrance of Alain Cribier
17 Feb 2024
It is with great sadness that PCR and the interventional cardiology community learnt of the death of Professor Alain Cribier, pioneer in the non-invasive treatment of valvular disease, superb doctor and professor of medicine and great humanist whose concern and care for his patients went beyond...

Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System
15 Feb 2022

Dynamx bioadaptor restores rotational motion and vessel stress reduction in new study
02 Jun 2022

30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.

Author

Author

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author
